|
Index of reports
> Disability (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zofran side effects in 4 month old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient: 4 month old male
Reactions: Death
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Zofran
Other drugs received by patient: NO Concurrent Medications
Possible Zofran side effects in 3 year old female
Reported by a physician from United States on 2012-04-27
Patient: 3 year old female, weighing 14.5 kg (31.9 pounds)
Reactions: Convulsion
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Zofran
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2011-12-25
Zofran
Administration route: Oral
Start date: 2011-12-28
Other drugs received by patient: NO Concurrent Medication
Possible Zofran side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-24
Patient: female, weighing 72.7 kg (159.9 pounds)
Reactions: Coma, Memory Impairment, Cardiac Arrest, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in 13 year old male
Reported by a consumer/non-health professional from United States on 2011-12-01
Patient: 13 year old male, weighing 40.8 kg (89.8 pounds)
Reactions: Self Esteem Decreased, Dystonia, Neck Pain, TIC
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in 71 year old male
Reported by a physician from United States on 2011-10-20
Patient: 71 year old male
Reactions: Dyspnoea, Hyperkalaemia, Atrial Fibrillation, Encephalopathy, Somnolence, Pulmonary Oedema, Renal Failure Acute, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Nexavar
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2009-11-02
End date: 2009-11-08
Nexavar
Administration route: Oral
Start date: 2009-11-09
End date: 2010-01-15
Zofran
Dosage: 4-8 mg, prn
Start date: 2010-01-06
End date: 2010-01-29
Other drugs received by patient: Procrit; Inderal LA; Torsemide; Imodium; Lactulose; Spironolactone; Allopurinol; Rifaximin; Lactulose; Prevacid; Allopurinol; Multi-Vitamin; Folic Acid
|
